Overview

Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders

Status:
Terminated
Trial end date:
2021-01-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the combined effect of melatonin and donepezil on improving sleep and behavior in children with Autism Spectrum Disorders. Melatonin is a natural neurohormone that helps regulate sleep and wake cycles. Donepezil is used to improve mental function for people with Alzheimer's disease. Children with Autism Spectrum Disorders are more likely to have problems sleeping than other children. This difficulty has been linked to daytime behavioral problems and family stress.
Phase:
Phase 2
Details
Lead Sponsor:
Stony Brook University
Collaborator:
Korea Institute of Science and Technology
Treatments:
Donepezil
Melatonin